实验性念珠菌性阴道炎中的保护性免疫 - Suppr

Protective immunity in experimental Candida vaginitis.

作者信息

Fidel P L, Sobel J D

机构信息

Department of Microbiology, Immunology, and Parasitology, Louisiana State University Medical Center, New Orleans 70112, USA.

出版信息

Res Immunol. 1998 May-Jun;149(4-5):361-73; discussion 510-2. doi: 10.1016/s0923-2494(98)80760-8.

DOI:10.1016/s0923-2494(98)80760-8

PMID:9720954

Abstract

摘要

相似文献

Protective immunity in experimental Candida vaginitis.

Res Immunol. 1998 May-Jun;149(4-5):361-73; discussion 510-2. doi: 10.1016/s0923-2494(98)80760-8.

[The problems of vaginal candidiasis. II. Protective mechanisms and the role of laboratory diagnosis].

Akush Ginekol (Sofiia). 1990;29(4):71-4.

Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Infect Immun. 2007 Oct;75(10):4675-86. doi: 10.1128/IAI.00083-07. Epub 2007 Jun 11.

Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects.

BJOG. 2015 May;122(6):785-794. doi: 10.1111/1471-0528.12994. Epub 2014 Jul 23.

The Case for an Expanded Concept of Trained Immunity.

mBio. 2018 May 22;9(3):e00570-18. doi: 10.1128/mBio.00570-18.

A Candida-specific antibody in patients with vaginitis.

Med J Aust. 1990 Apr 2;152(7):390-1. doi: 10.5694/j.1326-5377.1990.tb125254.x.

The protective immune response against vaginal candidiasis: lessons learned from clinical studies and animal models.

Int Rev Immunol. 2002 Nov-Dec;21(6):515-48. doi: 10.1080/08830180215015.

Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis.

J Med Vet Mycol. 1989;27(1):57-8.

Recurrent vulvovaginal candidiasis: why does it occur?

Int J STD AIDS. 1999 Jul;10(7):435-9; quiz 440-1. doi: 10.1258/0956462991914429.

Allergy in chronic monilial vaginitis.

Ann Allergy. 1971 May;29(5):266-7.

引用本文的文献

An estrogen-independent and IL-1-dependent pathway controls vulvovaginal candidiasis through combined IL-17/IL-22 signaling.

bioRxiv. 2025 Aug 28:2025.08.25.671995. doi: 10.1101/2025.08.25.671995.

Treatment for recurrent vulvovaginal candidiasis (thrush).

Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD009151. doi: 10.1002/14651858.CD009151.pub2.

New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome.

Mucosal Immunol. 2011 Jul;4(4):448-55. doi: 10.1038/mi.2011.5. Epub 2011 Feb 23.

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis.

J Exp Med. 2009 Feb 16;206(2):299-311. doi: 10.1084/jem.20081463. Epub 2009 Feb 9.

Animal models: an important tool in mycology.

Med Mycol. 2007 Dec;45(8):657-84. doi: 10.1080/13693780701644140.

Candidiasis--do we need to fight or to tolerate the Candida fungus?

Folia Microbiol (Praha). 2007;52(3):297-312. doi: 10.1007/BF02931313.

A novel glyco-conjugate vaccine against fungal pathogens.

J Exp Med. 2005 Sep 5;202(5):597-606. doi: 10.1084/jem.20050749.

Candida albicans yeast and germ tube forms interfere differently with human monocyte differentiation into dendritic cells: a novel dimorphism-dependent mechanism to escape the host's immune response.

Infect Immun. 2004 Feb;72(2):833-43. doi: 10.1128/IAI.72.2.833-843.2004.

Vaginal T lymphocyte population kinetics during experimental vaginal candidosis: evidence for a possible role of CD8+ T cells in protection against vaginal candidosis.

Clin Exp Immunol. 2003 Jan;131(1):26-33. doi: 10.1046/j.1365-2249.2003.02032.x.

Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.

Infect Immun. 2002 Oct;70(10):5462-70. doi: 10.1128/IAI.70.10.5462-5470.2002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Protective immunity in experimental Candida vaginitis.

作者信息

Fidel P L, Sobel J D

机构信息

Department of Microbiology, Immunology, and Parasitology, Louisiana State University Medical Center, New Orleans 70112, USA.

出版信息

Res Immunol. 1998 May-Jun;149(4-5):361-73; discussion 510-2. doi: 10.1016/s0923-2494(98)80760-8.

DOI:10.1016/s0923-2494(98)80760-8

PMID:9720954

Abstract

摘要

相似文献

Protective immunity in experimental Candida vaginitis.

Res Immunol. 1998 May-Jun;149(4-5):361-73; discussion 510-2. doi: 10.1016/s0923-2494(98)80760-8.

[The problems of vaginal candidiasis. II. Protective mechanisms and the role of laboratory diagnosis].

Akush Ginekol (Sofiia). 1990;29(4):71-4.

Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Infect Immun. 2007 Oct;75(10):4675-86. doi: 10.1128/IAI.00083-07. Epub 2007 Jun 11.

Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects.

BJOG. 2015 May;122(6):785-794. doi: 10.1111/1471-0528.12994. Epub 2014 Jul 23.

The Case for an Expanded Concept of Trained Immunity.

mBio. 2018 May 22;9(3):e00570-18. doi: 10.1128/mBio.00570-18.

A Candida-specific antibody in patients with vaginitis.

Med J Aust. 1990 Apr 2;152(7):390-1. doi: 10.5694/j.1326-5377.1990.tb125254.x.

The protective immune response against vaginal candidiasis: lessons learned from clinical studies and animal models.

Int Rev Immunol. 2002 Nov-Dec;21(6):515-48. doi: 10.1080/08830180215015.

Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis.

J Med Vet Mycol. 1989;27(1):57-8.

Recurrent vulvovaginal candidiasis: why does it occur?

Int J STD AIDS. 1999 Jul;10(7):435-9; quiz 440-1. doi: 10.1258/0956462991914429.

Allergy in chronic monilial vaginitis.

Ann Allergy. 1971 May;29(5):266-7.

引用本文的文献

An estrogen-independent and IL-1-dependent pathway controls vulvovaginal candidiasis through combined IL-17/IL-22 signaling.

bioRxiv. 2025 Aug 28:2025.08.25.671995. doi: 10.1101/2025.08.25.671995.

Treatment for recurrent vulvovaginal candidiasis (thrush).

Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD009151. doi: 10.1002/14651858.CD009151.pub2.

New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome.

Mucosal Immunol. 2011 Jul;4(4):448-55. doi: 10.1038/mi.2011.5. Epub 2011 Feb 23.

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis.

J Exp Med. 2009 Feb 16;206(2):299-311. doi: 10.1084/jem.20081463. Epub 2009 Feb 9.

Animal models: an important tool in mycology.

Med Mycol. 2007 Dec;45(8):657-84. doi: 10.1080/13693780701644140.

Candidiasis--do we need to fight or to tolerate the Candida fungus?

Folia Microbiol (Praha). 2007;52(3):297-312. doi: 10.1007/BF02931313.

A novel glyco-conjugate vaccine against fungal pathogens.

J Exp Med. 2005 Sep 5;202(5):597-606. doi: 10.1084/jem.20050749.

Candida albicans yeast and germ tube forms interfere differently with human monocyte differentiation into dendritic cells: a novel dimorphism-dependent mechanism to escape the host's immune response.

Infect Immun. 2004 Feb;72(2):833-43. doi: 10.1128/IAI.72.2.833-843.2004.

Vaginal T lymphocyte population kinetics during experimental vaginal candidosis: evidence for a possible role of CD8+ T cells in protection against vaginal candidosis.

Clin Exp Immunol. 2003 Jan;131(1):26-33. doi: 10.1046/j.1365-2249.2003.02032.x.

Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.

Infect Immun. 2002 Oct;70(10):5462-70. doi: 10.1128/IAI.70.10.5462-5470.2002.

Protective immunity in experimental Candida vaginitis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Protective immunity in experimental Candida vaginitis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献